Atlas Trials

Efficacy of Rituximab in Comparison to Continued Corticosteroid Treatment in Idiopathic Nephrotic Syndrome

Clinical trial NCT03298698 · UNKNOWN

Trial details

NCT number
NCT03298698
Sponsor
Radboud University Medical Center
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Idiopathic Nephrotic SyndromeMinimal Change DiseaseFocal Segmental Glomerulosclerosis
Start date
2018-08-22
Primary completion
2021-08-22
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.